BRPI0410355A - composição de vacina aviária para a proteção de aves contra doença e infecção causadas por e. coli e samonella - Google Patents

composição de vacina aviária para a proteção de aves contra doença e infecção causadas por e. coli e samonella

Info

Publication number
BRPI0410355A
BRPI0410355A BRPI0410355-6A BRPI0410355A BRPI0410355A BR PI0410355 A BRPI0410355 A BR PI0410355A BR PI0410355 A BRPI0410355 A BR PI0410355A BR PI0410355 A BRPI0410355 A BR PI0410355A
Authority
BR
Brazil
Prior art keywords
coli
vaccine composition
infection caused
samonella
protection
Prior art date
Application number
BRPI0410355-6A
Other languages
English (en)
Inventor
Henry H Fan
Mahesh Kumar
Original Assignee
Wyeth Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wyeth Corp filed Critical Wyeth Corp
Publication of BRPI0410355A publication Critical patent/BRPI0410355A/pt
Publication of BRPI0410355B1 publication Critical patent/BRPI0410355B1/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/025—Enterobacteriales, e.g. Enterobacter
    • A61K39/0258—Escherichia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/025—Enterobacteriales, e.g. Enterobacter
    • A61K39/0275—Salmonella
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/10—Transferases (2.)
    • C12N9/1085—Transferases (2.) transferring alkyl or aryl groups other than methyl groups (2.5)
    • C12N9/1092—3-Phosphoshikimate 1-carboxyvinyltransferase (2.5.1.19), i.e. 5-enolpyruvylshikimate-3-phosphate synthase
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/52—Bacterial cells; Fungal cells; Protozoal cells
    • A61K2039/522—Bacterial cells; Fungal cells; Protozoal cells avirulent or attenuated
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • A61K2039/552—Veterinary vaccine
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Microbiology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)

Abstract

"COMPOSIçãO DE VACINA AVIáRIA PARA A PROTEçãO DE AVES CONTRA DOENçA E INFECçãO CAUSADAS POR E. COLI E SALMONELLA". A presente invenção refere-se a uma composição de vacina compreendendo uma combinação de um microorganismo S. typhimurium mutante de deleção genética e um microorganismo E. coli mutante de deleção genética adequada para aplicação em massa a aves. é também provido um método seguro e eficaz para proteger aves contra as destruições de infecção e doença por E. coli e Salmonella.
BRPI0410355A 2003-05-14 2004-05-12 composição de vacina aviária para a proteção de aves contra doença e infecção causadas por e. coli e samonella BRPI0410355B1 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US47047003P 2003-05-14 2003-05-14
PCT/US2004/014836 WO2004103401A2 (en) 2003-05-14 2004-05-12 Avian combination-vaccine against e.coli and salmonella

Publications (2)

Publication Number Publication Date
BRPI0410355A true BRPI0410355A (pt) 2006-07-04
BRPI0410355B1 BRPI0410355B1 (pt) 2016-09-13

Family

ID=33476713

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0410355A BRPI0410355B1 (pt) 2003-05-14 2004-05-12 composição de vacina aviária para a proteção de aves contra doença e infecção causadas por e. coli e samonella

Country Status (14)

Country Link
US (1) US7297338B2 (pt)
EP (1) EP1622643A2 (pt)
JP (2) JP5500762B2 (pt)
KR (1) KR101150318B1 (pt)
CN (2) CN1787836A (pt)
AR (1) AR044339A1 (pt)
AU (1) AU2004240585B2 (pt)
BR (1) BRPI0410355B1 (pt)
CA (1) CA2524939C (pt)
MX (1) MXPA05012219A (pt)
NZ (1) NZ543558A (pt)
TW (1) TW200503755A (pt)
WO (1) WO2004103401A2 (pt)
ZA (1) ZA200509982B (pt)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7357935B2 (en) * 2003-05-14 2008-04-15 Wyeth Avian E. coli vaccine for protection against colibacillosis
US7935355B2 (en) * 2007-04-19 2011-05-03 Nutritional Health Institute Laboratories, Llc Composition and method for controlling intestinal pathogenic organisms
US20080260777A1 (en) * 2007-04-19 2008-10-23 Sotomayor Konky Composition and method for controlling intestinal pathogenic organisms
NZ607477A (en) 2008-09-26 2014-09-26 Ambrx Inc Non-natural amino acid replication-dependent microorganisms and vaccines
CN102140430B (zh) * 2011-01-13 2013-10-23 河南科技大学 一种不含抗性标记的鼠伤寒沙门氏菌基因缺失突变菌株、疫苗及应用
KR101518872B1 (ko) * 2013-05-14 2015-05-22 대한민국(관리부서 : 농림축산식품부 농림축산검역본부) 가금의 세균성 전신성 질병 원인균 진단용 프라이머 세트 및 상기 프라이머 세트를 포함하는 진단 키트
CN104711365B (zh) * 2015-04-02 2018-06-12 青岛康伦生物科技有限公司 沙门菌和大肠杆菌o78多重pcr快速检测的试剂盒
CN112618706B (zh) * 2020-11-21 2021-09-14 青岛博霖生物科技有限公司 沙门氏菌、鸭疫里默氏杆菌、大肠埃希氏杆菌病三联疫苗

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US400958A (en) * 1889-04-09 Leading-in apparatus for conduits
US650733A (en) * 1899-06-23 1900-05-29 William A Shaw Fire-escape.
GB8912330D0 (en) 1989-05-30 1989-07-12 Wellcome Found Live vaccines
JPH07206705A (ja) 1993-11-03 1995-08-08 American Cyanamid Co 生インオボ（ｉｎ ｏｖｏ）ワクチン
GB9806449D0 (en) * 1998-03-25 1998-05-27 Peptide Therapeutics Ltd Attenuated bacteria useful in vaccines
US7357935B2 (en) * 2003-05-14 2008-04-15 Wyeth Avian E. coli vaccine for protection against colibacillosis

Also Published As

Publication number Publication date
JP2012131796A (ja) 2012-07-12
NZ543558A (en) 2008-02-29
KR101150318B1 (ko) 2012-06-08
CN1787836A (zh) 2006-06-14
CA2524939A1 (en) 2004-12-02
CN102274495A (zh) 2011-12-14
BRPI0410355B1 (pt) 2016-09-13
JP5500762B2 (ja) 2014-05-21
EP1622643A2 (en) 2006-02-08
WO2004103401A3 (en) 2005-02-10
AU2004240585A1 (en) 2004-12-02
CA2524939C (en) 2012-12-04
JP2006528979A (ja) 2006-12-28
AU2004240585B2 (en) 2010-08-19
US7297338B2 (en) 2007-11-20
ZA200509982B (en) 2011-05-25
WO2004103401A2 (en) 2004-12-02
TW200503755A (en) 2005-02-01
MXPA05012219A (es) 2006-02-08
US20040234550A1 (en) 2004-11-25
KR20060012001A (ko) 2006-02-06
AR044339A1 (es) 2005-09-07

Similar Documents

Publication Publication Date Title
CY1107188T1 (el) Εμβολιο ε. coli πτηνου για την προστασια εναντι κολοβακτηριωσης
DE69935721D1 (de) Kälte-adaptierte pferde influenza-viren
BR9508633A (pt) Composição preparação de vacina estojo e processos para criar ou sustentar uma resposta imune protetora ou adaptadora a um antígeno em um hospedeiro e para induzir uma resposta imune protetora contra um organismo bacteriano enterotóxico
BRPI0415167A (pt) composto de amina como ligandos de canal de ìon e usos dos mesmos
CY1106634T1 (el) Θεραπευτικα παραγωγα της πιπεραζινης
BRPI0311323B8 (pt) composto inibidor de c-aril glicosídeo sglt2, composição farmacêutica e combinação
UY27843A1 (es) Composicion de vacuna
BRPI0410355A (pt) composição de vacina aviária para a proteção de aves contra doença e infecção causadas por e. coli e samonella
ECSP045353A (es) Derivados de benzoxazinona, su preparación y aplicación como medicamentos
BRPI0415179A (pt) derivados de amida como ligandos de canal de ìon e composições farmacêuticas e métodos de empregar as mesmas
WO2001060849A3 (en) Cold-adapted equine influenza viruses
CO6361950A2 (es) Composiciones, vacunas y metodos del virus del herpes del ganado bovino -1
BR9811319A (pt) Método para proteger um animal contra umadoença crÈnica
BRPI0411563A (pt) uso para derivados de estaurosporina
BR0311801A (pt) Composição de imidazol, método para produção do mesmo, composição farmacêutica, embalagem comercial, método para a profilaxia ou tratamento de doenças, método para erradicar helicobacter pylori de um animal infectado com helicobacter pylori, e, uso de um composto
BR0000190A (pt) Reovìrus de ave, processos para a preparação do mesmo, para controlar condições de doença que resultem de uma infecção de reovìrus de ave em aves domésticas e para a preparação de uma vacina para o uso na proteção de aves domésticas contra condições de doença que resultem de uma infecção de reovìrus de ave, e, vacina para o uso na proteção de aves domésticas.
AU4930001A (en) Cold-adapted equine influenza viruses
BR0108735A (pt) Proteção in ovo contra bronquite infecciosa
ES2098788T3 (es) Nueva bacteria que provoca enfermedades en las aves y vacuna derivada de esta bacteria.
BR0312640A (pt) Formulação contra mycoplasma gallisepticum
ES2127761T3 (es) Vacuna contra la dermatomicosis.
WO2007135420A3 (en) Defective interfering virus
DK1401279T3 (da) Acaricidpulver
HUP9700975A2 (hu) Élő, legyengített, Pasteurellaceae családba tartozó, RTX-termelő baktériumok
BR0102776A (pt) Mutante ibdv, vacina para uso na proteção de aves domésticas contra doença causada por infecção por ibdv, uso de um mutante ibdv, e, método para a proteção de aves domésticas contra doença causada por infecção por ibdv

Legal Events

Date Code Title Description
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B25D Requested change of name of applicant approved

Owner name: WYETH LLC (US)

B25A Requested transfer of rights approved

Owner name: PAH W LLC (US)

B25D Requested change of name of applicant approved

Owner name: ZOETIS W LLC (US)

B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B06A Patent application procedure suspended [chapter 6.1 patent gazette]
B06A Patent application procedure suspended [chapter 6.1 patent gazette]
B09A Decision: intention to grant [chapter 9.1 patent gazette]
B16A Patent or certificate of addition of invention granted [chapter 16.1 patent gazette]

Free format text: PRAZO DE VALIDADE: 10 (DEZ) ANOS CONTADOS A PARTIR DE 13/09/2016, OBSERVADAS AS CONDICOES LEGAIS.

B25A Requested transfer of rights approved
B25G Requested change of headquarter approved